An assessment of liver lesions using a combination of CEUS LI-RADS and AFP
- 5 February 2022
- journal article
- research article
- Published by Springer Nature in Abdominal Radiology
- Vol. 47 (4) , 1311-1320
Abstract
Purpose To improve noninvasive diagnosis of HCC using a combination of CE US LI-RADS and alpha-fetoprotein (AFP). Methods 757 solitary liver nodules from 757 patients at risk of HCC with CE US and serum AFP test were categorized as LR-1 to LR-5 through LR-M according to CE US LI-RADS version 2017. In LR-3, LR-4, and LR-M nodules, those with AFP > 200 ng/ml were reclassified as mLR-5. Nodules with LR-5 and mLR-5 were reclassified as definitely HCC to modify CE US LI-RADS. Diagnostic performance was assessed with specificity, sensitivity, and PPV. Results The sensitivity, specificity, and PPV of LR-5 as a predictor of HCC were 64.7%, 97.8%, and 98.9%, respectively. 32.1% patients with solitary liver nodule had AFP greater than 200 ng/ml, of which 98.8% were HCC (25.8%, 7.5%, 2.5% assigned to LR-M, LR-4, LR-3, respectively) and 1.2% were Combined Hepatocellular Cholangiocarcinoma. After modification, the sensitivity increased to 79.6% (P < 0.001), while specificity and PPV remained high (96.6% and 98.7%, P > 0.050). Conclusion The combination of CE US LI-RADS and AFP for diagnosing HCC improved diagnostic sensitivity significantly, while maintaining high PPV and specificity in patients with the solitary liver nodule. Graphical abstractKeywords
Funding Information
- National Natural Science Foundation of China (81971630, 82171960, 82102078)
- Guangzhou Municipal Science and Technology Program key projects (201904010187)
- Natural Science Foundation of Guangdong Province (2021B1515020054)
This publication has 38 references indexed in Scilit:
- Performance of serum α-fetoprotein levels in the diagnosis of hepatocellular carcinoma in patients with a hepatic massHPB, 2014
- Grading of hypervascular hepatocellular carcinoma using late phase of contrast enhanced sonography—A prospective studyDigestive and Liver Disease, 2011
- Management of Hepatocellular Carcinoma: An Update ΔσHepatology, 2011
- Des-γ-Carboxy Prothrombin and α-Fetoprotein as Biomarkers for the Early Detection of Hepatocellular CarcinomaGastroenterology, 2010
- Meta‐analysis: surveillance with ultrasound for early‐stage hepatocellular carcinoma in patients with cirrhosisAlimentary Pharmacology & Therapeutics, 2009
- Diagnostic accuracy of tumor markers for hepatocellular carcinoma: a systematic reviewHepatology International, 2007
- Hepatocellular Carcinoma and Hepatitis B VirusSeminars in Liver Disease, 2006
- Management of Hepatocellular Carcinoma *Hepatology, 2005
- Resection of Hepatocellular Carcinoma Without Preoperative Tumor BiopsyAnnals of Surgery, 2001
- α‐fetoprotein‐producing rectal cancer: Calculated tumor marker doubling timeJournal of Surgical Oncology, 1994